Literature DB >> 21999527

Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease.

T Hershcovici1, L K Jha, T Johnson, L Gerson, C Stave, J Malo, K S Knox, S Quan, R Fass.   

Abstract

BACKGROUND  A potential relationship has been suggested between gastro-oesophageal reflux disease (GERD) and interstitial lung diseases (ILDs). AIM  To evaluate whether there is a causal relationship between GERD and different ILDs. METHODS  We conducted a systematic search of literature published between 1980 and 2010. After a review by two independent authors, each study was assigned an evidence-based rating according to a standard scoring system. RESULTS  We identified 319 publications and 22 of them met the entry criteria. Of those, the relationship between GERD and idiopathic pulmonary fibrosis (IPF) was investigated in 14 articles, pulmonary involvement in systemic sclerosis (SSc) in six articles and pulmonary involvement in mixed connective tissue disease (MCTD) in two articles. We found the prevalence of GERD and/or oesophageal dysmotility to be higher in patients with different types of ILD as compared with those without ILD [Evidence B]. Among patients with IPF, 67-76% demonstrated abnormal oesophageal acid exposure off PPI treatment. No relationship was demonstrated between severity of GERD and severity of IPF [Evidence B]. Data are scant on outcomes of antireflux treatment in patients with IPF. There is a correlation between the severity of ILD and the degree of oesophageal motor impairment in patients with SSc and MCTD [Evidence B]. CONCLUSIONS  Based on the currently available data, a causal relationship between GERD and idiopathic pulmonary fibrosis cannot be established. There is scant evidence about antireflux therapy in idiopathic pulmonary fibrosis patients. There may be an association between lung and oesophageal involvement in systemic sclerosis and mixed connective tissue disease, but a causal relationship cannot be established.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21999527     DOI: 10.1111/j.1365-2036.2011.04870.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  12 in total

Review 1.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

2.  The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

Authors:  J N Kimmel; D A Carlson; M Hinchcliff; M A Carns; K A Aren; J Lee; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2016-02-27       Impact factor: 3.598

3.  Gastrointestinal Manifestations of Systemic Sclerosis.

Authors:  Andrew B Shreiner; Charles Murray; Christopher Denton; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2016-10-18

Review 4.  Advances in the evaluation and management of esophageal disease of systemic sclerosis.

Authors:  Dustin A Carlson; Monique Hinchcliff; John E Pandolfino
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

5.  Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.

Authors:  Michael Kreuter; Paolo Spagnolo; Wim Wuyts; Elisabetta Renzoni; Dirk Koschel; Francesco Bonella; Toby M Maher; Martin Kolb; Derek Weycker; Klaus-Uwe Kirchgässler; Ulrich Costabel
Journal:  Respiration       Date:  2017-04-12       Impact factor: 3.580

6.  Pepsin concentrations are elevated in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis after lung transplantation.

Authors:  Christopher S Davis; Bernardino M Mendez; Diana V Flint; Karen Pelletiere; Erin Lowery; Luis Ramirez; Robert B Love; Elizabeth J Kovacs; P Marco Fisichella
Journal:  J Surg Res       Date:  2013-06-29       Impact factor: 2.192

Review 7.  Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis.

Authors:  Thiago Mamôru Sakae; Márcia Margaret Menezes Pizzichini; Paulo José Zimermann Teixeira; Rosemeri Maurici da Silva; Daisson José Trevisol; Emilio Pizzichini
Journal:  J Bras Pneumol       Date:  2013 May-Jun       Impact factor: 2.624

8.  Idiopathic pulmonary fibrosis and GERD: links and risks.

Authors:  Matteo Ghisa; Carla Marinelli; Vincenzo Savarino; Edoardo Savarino
Journal:  Ther Clin Risk Manag       Date:  2019-09-05       Impact factor: 2.423

9.  Gastric Acid and Pepsin Work Together in Simulated Gastric Acid Inhalation Leading to Pulmonary Fibrosis in Rats.

Authors:  Shi Chen; HongYu Chen; Yue Cheng; Yu Wei; XianMei Zhou; Tian Li; JiPing Zhu; Qian Wang
Journal:  Med Sci Monit       Date:  2019-08-16

10.  Pulmonary Disease Secondary to Reflux Mimicking Interstitial Pneumonia in Systemic Sclerosis: Case Report and Literature Review.

Authors:  Ricardo Azêdo de Luca Montes; Nathalia Mazolli Veiga; Pedro Gemal Lanzieri; Luis Otávio Cardoso Mocarzel
Journal:  Case Rep Rheumatol       Date:  2016-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.